Rybelsus 7 mg tablets clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)
This study is looking at a new tablet, semaglutide, to see if it can help people with early Alzheimer's disease. Researchers want to know if it's safe and if it can slow down changes in memory and thinking over about two years.
For: Mild cognitive impairment (MCI) or mild dementia · both of the Alzheimer’s typeRomania · Bulgaria · Belgium - Ongoing, recruitingTherapeutic confirmatory (Phase III)
PIONEER TEENS Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes.
This study is looking at a medicine called Rybelsus for teenagers with type 2 diabetes. It wants to see if Rybelsus, taken with other common diabetes medicines, helps control blood sugar and is safe. The study compares Rybelsus to a dummy pill to understand its effects better.
For: Type 2 diabetesGreece · Czechia · Portugal - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE)
This study is testing a new medicine called semaglutide for people with early Alzheimer's disease. Researchers want to see if it can help improve memory and thinking, and how safe it is to use.
For: Mild cognitive impairment (MCI) or mild dementia · both of the Alzheimer’s typeItaly · Bulgaria · Romania - AuthorisedTherapeutic exploratory (Phase II)
Effects of GLP-1 analogue in multiple sclerosis
This study is looking at how a specific type of medicine, usually for diabetes, might affect the brains of people with multiple sclerosis (MS). Researchers want to see if it can slow down brain changes and improve memory or thinking skills.
For: Patients with confirmed multiple sclerosis (MS) · with worse prognosis given the higher disease activity · in productive age between 18 and 60 yearsSlovakia - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase Ilb, Randomized, Double-blind, Placebo controlled and Open-label Active Comparator Study to Evaluate the Efficacy, Safety, and Tolerability of AZD5004 in Adults with Type 2 Diabetes Mellitus
This study is looking at a new medicine called AZD5004 for adults with Type 2 Diabetes. Researchers want to see how well it lowers blood sugar (HbA1c) and if it's safe, compared to a widely used medicine (Rybelsus) or a dummy pill.
For: Type 2 Diabetes MellitusHungary · Germany · Poland